Research Site — Omaha, Nebraska

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

618

Registered studies

184

Active

Recruiting now

353

Completed

Stopped or withdrawn

Most-studied conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Advanced Non-Small Cell Lung Cancer · Metastatic Clear Cell Renal Cell Carcinoma · Oligometastatic Prostate Cancer (OMPC)

Recently updated registry entries

NCT02453282 — Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without… (Active Not Recruiting)
NCT05543616 — A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy… (Completed)
NCT04640142 — Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.